Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Psychiatry Clear all

Conditions: Parkinson's Disease
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Intensive Care Unit Syndrome, Intensive Care Neurological Disorder, Intensive Care (ICU) Myopathy, Intensive Care Psychiatric Disorder (Diagnosis)
Interventions: VANDERBILT ICU RECOVERY PROGRAM; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Psychiatric Illness, Healthy
Interventions: GLYX-13, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brain Injury, Dementia, Healthy, Mental Disorder, Schizophrenia
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 810 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Depression - Major Depressive Disorder
Interventions: Approach-Avoidance Decision-Making Task; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Depression, Mild Cognitive Impairment
Interventions: IV Ketamine; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pervasive Child Development Disorders, Autism
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 2 Years to 9 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 2
States / cities: New Haven, Connecticut • Chicago, Illinois

Conditions: HIV Infections
Interventions: group intervention; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 13 Years to 19 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2007
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Anorexia Nervosa
Interventions: quetiapine; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Mental Disorder, Physical Illness
Interventions: Integrated Care, Peer Navigation; Behavioral
Lead sponsor: Illinois Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Unemployment
Interventions: Purposeful Pathways, Transitional Work Experience; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: Self-Injurious Behavior, Suicidal Ideation, Suicide Attempts
Interventions: Therapeutic Evaluative Conditioning, Neutral comparison condition; Behavioral
Lead sponsor: Franciscan Hospital For Children, INC.; Other
Eligibility: 12 Years to 19 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: Autism Spectrum Disorder, Mental Health Issue
Interventions: ATTAIN; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 4 Years to 16 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Behavioral and Psychiatric Symptoms of Dementia, Alzheimer Disease, Lewy Body Disease, Frontotemporal Dementia
Interventions: Music therapy intervention, Personalized music CD; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years to 110 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Wilkes-Barre, Pennsylvania

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Glen Oaks, New York

Conditions: Bipolar I Disorder
Interventions: AL001, Lithium carbonate; Drug
Lead sponsor: Alzamend Neuro, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Impulse Control Disorders
Interventions: Not listed
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Psychotic Disorders
Interventions: Mobile After-Care Support (MACS) app; Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Advanced Cancer
Interventions: Psilocybin 25 mgs, Niacin 100mg, Psychotherapy; Drug · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • New York, New York

Conditions: Syncope
Interventions: midodrine; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 16 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Depression, Bipolar Disorder, Anxiety Disorders, Psychiatric Disorder
Interventions: I-Change, Symptom Tracking; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Postpartum Psychiatric Disorders
Interventions: Digital Mindfulness Training; Behavioral
Lead sponsor: Nina Ayala; Other
Eligibility: 18 Years and older · Female only
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: Schizophrenic Disorders
Interventions: Psychiatric Rehabilitation Approach to Weight Loss; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 65 Years
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Attention Deficit and Disruptive Behavior Disorder, Attention Deficit Disorder With Hyperactivity
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 6 Years to 17 Years
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1985 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Vanderbilt ICU Recovery Program Pilot Trial

Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia

Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease

Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

Longitudinal and Biological Study of Childhood Disintegrative Disorder

HIV, Abuse, and Psychiatric Disorders Among Youth

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

Peer Navigators for the Health and Wellness of People With Psychiatric Disabilities

Improving Vocational Outcomes of Veterans With Psychiatric Disorders: Career Counseling & Development

Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization

Access to Tailored Autism Integrated Care Pilot Study

Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study

Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Fingerprinting of Impulsivity

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

Psilocybin Therapy in Advanced Cancer

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Augmenting Hospitalization for Serious Mental Illness: Cognitive Bias Modification

Mindfulness, Optimism, and Resilience for Perinatal Health and Empowerment Study

The Psychiatric Rehabilitation Approach to Weight Loss

Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)